Metformin intake associates with better cognitive function in patients with Huntington's disease

• David Hervás,

  Affiliation Department of Biostatistics, Health Research Institute La Fe (Hospital Universitario y Politécnico La Fe), Valencia, Spain

  ⨯
• Victoria Fornés-Ferrer,

  Affiliation Department of Biostatistics, Health Research Institute La Fe (Hospital Universitario y Politécnico La Fe), Valencia, Spain

  ⨯
• Ana Pilar Gómez-Escribano,

  Affiliation Research Group in Molecular, Cellular and Genomic Biomedicine, Health Research Institute La Fe (Hospital Universitario y Politécnico La Fe), Valencia, Spain

  ⨯
• María Dolores Sequedo,

  Affiliations Research Group in Molecular, Cellular and Genomic Biomedicine, Health Research Institute La Fe (Hospital Universitario y Politécnico La Fe), Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯
• Carmen Peiró,

  Affiliation Department of Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain

  ⨯
• José María Millán,

  Affiliations Research Group in Molecular, Cellular and Genomic Biomedicine, Health Research Institute La Fe (Hospital Universitario y Politécnico La Fe), Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯
• Rafael P. Vázquez-Manrique

  * E-mail: rafael_vazquez@iislafe.es

  Affiliations Research Group in Molecular, Cellular and Genomic Biomedicine, Health Research Institute La Fe (Hospital Universitario y Politécnico La Fe), Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯